{"filing":{"accession_number":"0001581280-26-000050","cik":"0001581280","ticker":"TWST","company_name":"Twist Bioscience Corp","form":"8-K","filing_date":"2026-08-18","report_date":"2026-08-18","primary_document":"twist-20260818.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1581280/000158128026000050/twist-20260818.htm"},"events":[{"id":28346,"run_id":25918,"accession_number":"0001581280-26-000050","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"summary":"Twist Bioscience has been selected by Anthropic as an independent evaluator to produce and test AI-designed proteins at scale, representing a material business opportunity and partnership validation. This is a strategic operational development—a significant contract or engagement with a major AI company—that does not fit the specific operational categories (workforce reduction, restructuring, etc.) but clearly affects the registrant's business prospects and competitive positioning.","company_name":"Twist Bioscience Corp","ticker":"TWST","filing_date":"2026-08-18","form":"8-K","submitted_at":null,"items":[{"id":30264,"accession_number":"0001581280-26-000050","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"Twist Bioscience has been selected by Anthropic as an independent evaluator to produce and test AI-designed proteins at scale, representing a material business opportunity and partnership validation. This is a strategic operational development—a significant contract or engagement with a major AI company—that does not fit the specific operational categories (workforce reduction, restructuring, etc.) but clearly affects the registrant's business prospects and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T10:02:39.775299+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30264,"accession_number":"0001581280-26-000050","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"reasoning":"Twist Bioscience has been selected by Anthropic as an independent evaluator to produce and test AI-designed proteins at scale, representing a material business opportunity and partnership validation. This is a strategic operational development—a significant contract or engagement with a major AI company—that does not fit the specific operational categories (workforce reduction, restructuring, etc.) but clearly affects the registrant's business prospects and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T10:02:39.775299+00:00","company_name":"Twist Bioscience Corp","ticker":"TWST","filing_date":"2026-08-18"}]}